Approaches

Get the Latest Information on Medical Marijuana with On-line Education

by

OSUWexnerbloglogo2014 Get the Latest Information on Medical Marijuana with On-line Education. One of the most recent states to legalize medical marijuana is Ohio where a new medical marijuana law went into effect earlier this month. But it is not without controversy, however. And it is really difficult to find objective, scientific data on the medicinal effects of marijuana. On this CME webcast, we’ve brought in two of the Ohio State University’s top experts on marijuana to give us an unbiased review of medical marijuana and we’re going to frame the discussion in the context of Ohio’s new medical marijuana law. To review the pharmacology of marijuana, palliative medicine clinical pharmacist, and to tell us more about the medical uses of marijuana is Professor of Internal Medicine and the long-standing chairman of the OSU Pharmacy and Therapeutics committee, Dr. Harrison Weed.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND the currently accepted appropriate uses of medical marijuana; and UNDERSTAND the potential
adverse consequences of medical marijuana.

You’ll also learn about the following:

  • Current pharmacologic uses of cannabinoids
  • Medicinal properties of marijuana
  • Hemp versus marijuana
  • The Ohio Automated Rx Reporting System (OARRS)
  • Hospital approaches to inpatient use of medical marijuana
  • Purity testing and labeling

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn About New Drugs for Lipid Management

by

OSUWexnerbloglogo2014 Learn About New Drugs for Lipid Management. Managing hyperlipidemia used to be so easy. If a patient’s total cholesterol was greater than 200, then we started them on lovastatin to reduce it. But things are a lot more complicated now. There isn’t a single cholesterol target for all patients and we have gone way beyond statins as the only game in town for cholesterol management. On this CME webcast, we’re going to update you on the newest developments in lipid management. What tests to order, who to treat and which drugs to use. Joining our moderator in the studio is cardiologist and Associate Professor of Internal Medicine, Dr. John Larry and pharmacist and Assistant Professor of Pharmacy, Melissa Snider.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: REVIEW updates in approaches to treatment of dyslipidemia; DISCUSS recent evidence for non-statin lipid lowering therapies; DISCUSS place in therapy of available lipid lowering therapies; and REVIEW clinical approach to statin intolerance.

You’ll also learn about the following:

  • Patient-specific cholesterol targets
  • Multidisciplinary lipid clinics at the OSU Wexner Medical Center
  • The expanding role of pharmacists in outpatient clinical practice
  • Diet and cholesterol

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn about Breast Cancer Treatment on CME Webcast

by

OSUWexnerbloglogo2014 Learn About Breast Cancer Treatment on CME Webcast. Joining our moderator in the studio to tell us about many of the new treatments available to patients are two of Ohio State’s top experts in breast cancer. First, to tell us about the surgical management of breast cancer, we have surgical oncologist and Associate Professor of Surgery, Dr. Doreen Agnese. And then, to tell us about medications used in breast cancer, will be medical oncologist and Assistant Professor of Internal Medicine, Dr. Raquel Reinbolt.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: REVIEW breast cancer systemic therapy approaches for early stage, locally advanced, and (briefly) metastatic breast cancer; REVIEW principles of survivorship; UNDERSTAND the current recommendations for screening and diagnosis of breast; and UNDERSTAND the surgical therapies for breast cancer and their consequences.

You’ll also learn about the following:

  • Surgical treatment options for breast cancer
  • New insights into breast cancer subtypes
  • Common side effects of treatment
  • The role of primary care in management of the breast cancer survivor

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn about Insomnia on On-line CME Webcast

by

OSUWexnerbloglogo2014 Learn about Insomnia on On-line CME Webcast. For many people, insomnia is a nightly occurrence, leading to nocturnal frustration and daytime fatigue. On this CME webcast, we’re going to explore insomnia, what causes it and what you can advise your patients to do about it. Our guests today are specialists in sleep medicine. Dr. Meena Khan is an Assistant Professor of Internal Medicine and of Neurology, and Dr. Jesse Mindel, who is an Assistant Professor of Neurology.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: REVIEW basic approaches to insomnia treatment; REVIEW available behavioral and pharmacologic therapies for insomnia; Describe the epidemiology and health implications of chronic insomnia; DESCRIBE the psychological characteristic of those with chronic insomnia; and DESCRIBE the behavioral and environmental factors that perpetuate chronic insomnia.

You’ll also learn about the following:

  • Common causes of insomnia
  • Normal sleep patterns
  • Melatonin
  • Sleep binging
  • Circadian rhythm disturbances
  • Eye patches and background noise recordings
  • Antihistamines
  • Approach to the patient who wakes up and cannot fall back to sleep
  • Approach to temporary situational insomnia

You can find this and many other MedNet21 programs on the OSU – CCME website.
Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.